- Nachrichtendetail
-
29.04.2024 12:02:27 - dpa-AFX: *REPERTOIRE® IMMUNE MEDICINES, BRISTOL MYERS SQUIBB ENTER STRATEGIC COLLABORATION TO DEVELOP TOLERIZING VACCINES
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Co | 850501 | NYSE | 41,155 | 16.07.24 21:35:11 | +1,005 | +2,50% | 41,150 | 41,160 | 40,150 | 40,150 |
